182 results
Page 2 of 10
8-K
EX-10.1
n1eiw32p7 8ozhnk1s
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.4
khbx8u9zez3zj2l
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.5
t058tvb4
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
h3osv
22 Sep 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
EX-10.1
vmbo11hvm
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.1
h1ontewk3o8bghttqu2
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.3
d2z023r6
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.2
gd6bbo
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
S-8
w1lxavk
22 Apr 22
Registration of securities for employees
4:20pm
S-8
EX-23.1
rstwo2 rrsep3zx
22 Apr 22
Registration of securities for employees
4:20pm
8-K
EX-99.1
xj3 d06ukhphv
31 Mar 22
Aravive Reports Fourth Quarter and Full Year 2021
4:05pm
8-K
EX-4.3
s49aiizehdlhljxvhfq
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-10.1
6kz7 u14s6xpp
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-4.2
pgynkiqji1hq 5m
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-4.1
7nddk
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-10.2
udr2t
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
424B5
bg8q116h8ec0v
31 Mar 22
Prospectus supplement for primary offering
6:06am